My Thoughts

Leveraging my experience as a co-founder of a biotechnology start-up, corporate development leader, and investor to discuss tactical and strategic considerations for building great biotech and pharma companies.

(Don’t Fear) The Partner: Why Signing An Early Strategic Biotech Partnership is Not the Beginning of the End

Drew Hertig, MBA, CLP

Jun 188 min

(Don’t Fear) The Partner: Why Signing An Early Strategic Biotech Partnership is Not the Beginning of the End

Here are three common fears regarding early-stage strategic partnerships, and ways a founder or investor can overcome them to be successful.

56 views0 comments

3 Ways Artificial Intelligence Will Unlock Substantial Value in Drug Development

Drew Hertig, MBA, CLP

Feb 68 min

3 Ways Artificial Intelligence Will Unlock Substantial Value in Drug Development

Artificial Intelligence/Machine Learning (AI/ML) has the potential to significantly lower the costs of drug development and improve...

103 views0 comments